Keywords: pharmaxis, begins, uk, phase, ii, bronchitol, australian

Pharmaxis begins UK Phase II for Bronchitol

Article | 21 February 2005

Print This

Australian drug developer Pharmaxis has received approval to start a Phase II study in the UK with its cystic fibrosis ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in